Ameriprise’s Cartesian Therapeutics RNAC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-11,716
| Closed | -$242K | – | 3943 |
|
|
2023
Q4 | $242K | Sell |
11,716
-1,782
| -13% | -$36.9K | ﹤0.01% | 3671 |
|
|
2023
Q3 | $429K | Sell |
13,498
-120
| -0.9% | -$3.82K | ﹤0.01% | 3467 |
|
|
2023
Q2 | $458K | Buy |
13,618
+657
| +5% | +$22.1K | ﹤0.01% | 3471 |
|
|
2023
Q1 | $540K | Buy |
12,961
+3,673
| +40% | +$153K | ﹤0.01% | 3400 |
|
|
2022
Q4 | $316K | Sell |
9,288
-182
| -2% | -$6.19K | ﹤0.01% | 3565 |
|
|
2022
Q3 | $466K | Sell |
9,470
-290
| -3% | -$14.3K | ﹤0.01% | 3417 |
|
|
2022
Q2 | $383K | Sell |
9,760
-4,038
| -29% | -$158K | ﹤0.01% | 3482 |
|
|
2022
Q1 | $509K | Buy |
13,798
+4,101
| +42% | +$151K | ﹤0.01% | 3480 |
|
|
2021
Q4 | $949K | Buy |
+9,697
| New | +$949K | ﹤0.01% | 3280 |
|
|
2021
Q3 | – | Sell |
-1,372
| Closed | -$172K | – | 3937 |
|
|
2021
Q2 | $172K | Sell |
1,372
-1,511
| -52% | -$189K | ﹤0.01% | 3771 |
|
|
2021
Q1 | $391K | Sell |
2,883
-143
| -5% | -$19.4K | ﹤0.01% | 3488 |
|
|
2020
Q4 | $275K | Buy |
3,026
+1,559
| +106% | +$142K | ﹤0.01% | 3521 |
|
|
2020
Q3 | $109K | Sell |
1,467
-133
| -8% | -$9.88K | ﹤0.01% | 3630 |
|
|
2020
Q2 | $136K | Buy |
+1,600
| New | +$136K | ﹤0.01% | 3554 |
|
|
2018
Q4 | – | Sell |
-4,502
| Closed | -$2.1M | – | 3741 |
|
|
2018
Q3 | $2.1M | Buy |
4,502
+1,722
| +62% | +$803K | ﹤0.01% | 2798 |
|
|
2018
Q2 | $1.11M | Buy |
+2,780
| New | +$1.11M | ﹤0.01% | 2974 |
|